Skip to main content

Parathyroid Hormone Injection Shortage

Last Updated: August 15, 2025
Status: Current

Unavailable, Current:

Limited Availability, Current:

Natpara, Injection, 100 ug/.08 mL, Injection, Powder, Lyophilized, For Solution (Takeda Pharmaceuticals USA Inc.)

NDC Code: 68875-0205-2
Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: The 100 Mcg Cartridge Is No Longer Available And Takeda Is Unable To Resupply Prior To Ceasing Of Manufacturing Of Natpara At The End Of 2024.
Therapeutic category: Endocrinology/Metabolism
Initial posting date: September 11, 2019
Contact info: 866-888-0660

Natpara, Injection, 25 ug/.08 mL, Injection, Powder, Lyophilized, For Solution (Takeda Pharmaceuticals USA Inc.)

NDC Code: 68875-0202-2
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Takeda will be ceasing manufacturing of Natpara at the end of 2024 with a priority to maintain treatment continuity for patients enrolled in the U.S. Special Use Program until inventory is depleted or expired.
Therapeutic category: Endocrinology/Metabolism
Initial posting date: September 11, 2019
Contact info: 866-888-0660

Natpara, Injection, 50 ug/.08 mL, Injection, Powder, Lyophilized, For Solution (Takeda Pharmaceuticals USA Inc.)

NDC Code: 68875-0203-2
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Takeda will be ceasing manufacturing of Natpara at the end of 2024 with a priority to maintain treatment continuity for patients enrolled in the U.S. Special Use Program until inventory is depleted or expired.
Therapeutic category: Endocrinology/Metabolism
Initial posting date: September 11, 2019
Contact info: 866-888-0660

Natpara, Injection, 75 ug/.08 mL, Injection, Powder, Lyophilized, For Solution (Takeda Pharmaceuticals USA Inc.)

NDC Code: 68875-0204-2
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Takeda will be ceasing manufacturing of Natpara at the end of 2024 with a priority to maintain treatment continuity for patients enrolled in the U.S. Special Use Program until inventory is depleted or expired.
Therapeutic category: Endocrinology/Metabolism
Initial posting date: September 11, 2019
Contact info: 866-888-0660

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer